Form 4: Research Frontiers Inc. VP-Marketing Acquires Stock Options

Michael R. LaPointe, VP-Marketing at Research Frontiers Inc., was granted 6,000 stock options, with 3,725 contingent on shareholder approval.

Summary

• Michael R. LaPointe, the VP-Marketing of Research Frontiers Inc., received 6,000 stock options on December 31, 2024.
• The options have an exercise price of $1.68 per share.
• 3,725 of these options are contingent on shareholder approval at the 2025 Annual Meeting of Stockholders for additional shares under the 2019 Equity Incentive Plan.
• If shareholder approval is not obtained, these 3,725 options will be automatically terminated.
• The options expire on December 30, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. The contingency on shareholder approval adds a slight element of uncertainty but is a common practice.

Positives

• The grant of stock options to a key executive like the VP-Marketing can be seen as an incentive to align their interests with the company's performance.
• The vesting of a portion of the options is contingent on shareholder approval, which could encourage management to act in the best interests of shareholders.

Negatives

• The contingency of 3,725 options on shareholder approval introduces uncertainty regarding the final number of options granted.

Risks

• If shareholders do not approve the additional shares at the 2025 Annual Meeting, 3,725 of the granted options will be terminated, potentially impacting executive motivation.
• The value of the options is dependent on the future performance of the company's stock price.

Future Outlook

The grant of stock options is part of the company's 2019 Equity Incentive Plan and is intended to incentivize key personnel. The vesting of a portion of the options is contingent on shareholder approval at the 2025 Annual Meeting.

Industry Context

Stock option grants are a common practice in publicly traded companies to incentivize executives and align their interests with those of shareholders. This is a standard form 4 filing for a stock option grant.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation across various industries, particularly in technology and growth-oriented companies.
• The specific terms of the grant, such as the exercise price and vesting schedule, are typical for such arrangements.
• The contingency on shareholder approval is a measure to ensure alignment with shareholder interests, which is a common practice in corporate governance.

Stakeholder Impact

• Shareholders will need to vote on the approval of additional shares at the 2025 Annual Meeting, which will impact the vesting of a portion of the options.
• The grant of options could incentivize the VP-Marketing to improve company performance, which would benefit shareholders.

Next Steps

• Shareholder approval will be sought at the 2025 Annual Meeting of Stockholders for the additional shares required for the contingent options.

Key Dates

Keywords

stock options, equity incentive plan, shareholder approval, executive compensation, Research Frontiers Inc., REFR, insider trading